Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial

被引：0
|
作者：
Tong Zhang
Mingrun Lin
Wangen Li
Xiuyun Fan
Tao Du
Yunjuan Zhao
Xiaodan Zhang
机构：
[1] The Third Affiliated Hospital of Southern Medical University,Department of Endocrinology and Metabolism
[2] The Second Affiliated Hospital of Guangzhou Medical University,Department of Endocrinology
来源：
Advances in Therapy | 2016年 / 33卷
关键词：
Endocrinology; Hyperglycemia; Insulin detemir; Insulin glargine; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [1] Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial
    Zhang, Tong
    Lin, Mingrun
    Li, Wangen
    Fan, Xiuyun
    Du, Tao
    Zhao, Yunjuan
    Zhang, Xiaodan
    [J]. ADVANCES IN THERAPY, 2016, 33 (02) : 178 - 185
  • [2] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [3] COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES
    Galindo, Rodolfo J.
    Davis, Georgia M.
    Fayfman, Maya
    Reyes-Umpierrez, David
    Alfa, David
    Peng, Limin
    Tamler, Ronald
    Pasquel, Francisco J.
    Umpierrez, Guillermo E.
    [J]. ENDOCRINE PRACTICE, 2017, 23 (09) : 1059 - 1066
  • [4] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [5] A randomized, crossover, double-blind comparison of insulin detemir and insulin glargine daily blood glucose profiles in subjects with type 2 diabetes
    King, Allen B.
    Armstrong, Dana U.
    [J]. DIABETES, 2008, 57 : A130 - A130
  • [6] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes
    Yamada K.
    Nakayama H.
    Sato S.
    Tajiri Y.
    Kaku H.
    Tokubuchi I.
    Kato T.
    Soejima E.
    Ohki T.
    [J]. Diabetology International, 2014, 5 (1) : 74 - 77
  • [7] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2011, 54 : S420 - S421
  • [8] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [9] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    [J]. ENDOCRINE JOURNAL, 2017, 64 (02) : 133 - 140
  • [10] A Randomized Crossover Study of the Efficacy and Safety of Switching from Insulin Glargine to Insulin Degludec in Children with Type 1 Diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    [J]. DIABETES, 2015, 64 : A366 - A366
12345